1998
DOI: 10.1007/s001250051075
|View full text |Cite
|
Sign up to set email alerts
|

Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway

Abstract: The intracellular mechanism responsible for insulin receptor-mediated stimulation of glucose transport is partly understood [1±4]. In contrast, much less is known about the signalling pathways that couple the insulin receptor to lipid metabolism. In fat cells, insulin inhibits the mobilization of non-esterified fatty acids (NEFA) in two synergistic ways [5]. Firstly, insulin decreases the rate of lipolysis (i. e. activates antilipolysis). Secondly, insulin increases the rate of re-synthesis of triglycerides fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
127
5
8

Year Published

2002
2002
2012
2012

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 189 publications
(147 citation statements)
references
References 33 publications
7
127
5
8
Order By: Relevance
“…However, this was not the case, indeed, not even at the highest concentration of rosiglitazone did the PPRE activity in omental fat cells reach basal levels in subcutaneous fat cells. Since increased PPARG activity through treatment with synthetic PPARG activators leads to reduced adipose tissue lipolytic activity and lowered levels of NEFA in plasma, this novel finding of low PPARG activity is in line with the high lipolytic activity in intra-abdominal fat tissue [8].…”
Section: Discussionmentioning
confidence: 53%
See 2 more Smart Citations
“…However, this was not the case, indeed, not even at the highest concentration of rosiglitazone did the PPRE activity in omental fat cells reach basal levels in subcutaneous fat cells. Since increased PPARG activity through treatment with synthetic PPARG activators leads to reduced adipose tissue lipolytic activity and lowered levels of NEFA in plasma, this novel finding of low PPARG activity is in line with the high lipolytic activity in intra-abdominal fat tissue [8].…”
Section: Discussionmentioning
confidence: 53%
“…Our study also shows that the difference cannot be compensated even by the potent synthetic PPARG agonist rosiglitazone. Further studies into the molecular mechanisms behind the large difference in PPARG signalling in the two adipose tissue depots could lead to the development of drugs that reduce the adverse metabolic effect of abdominal obesity and the poor cardiovascular prognosis linked to this condition [2,8,24].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In our study the A allele of SNP-43 was associated with intraabdominal fat area even after the adjustment for insulin sensitivity. The GG genotype has been associated with improved insulin action in isolated subcutaneous adipocytes [31], which could explain the preferential storage of fat in subcutaneous depots, in contrast to intra-abdominal fat that is less sensitive to insulin action [32]. Lower accumulation of intra-abdominal fat could then explain better whole-body insulin sensitivity in subjects with the GG genotype in this study.…”
Section: Subjects Inmentioning
confidence: 54%
“…Adipocytes were incubated [21]. An aliquot (2 ml) of adipocytes (15% cell suspension) was incubated for 10 min at 37°C in the absence or presence of 3 or 1000 nmol/l insulin.…”
Section: Subject Characteristics and Dietary Interventionmentioning
confidence: 99%